- Home
- IPG vs CORT Comparison
IPG vs CORT Comparison
Compare IPG & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPG
- CORT
- Stock Information
- Founded
- IPG 1902
- CORT 1998
- Country
- IPG United States
- CORT United States
- Employees
- IPG N/A
- CORT N/A
- Industry
- IPG Advertising
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- IPG Consumer Discretionary
- CORT Health Care
- Exchange
- IPG Nasdaq
- CORT Nasdaq
- Market Cap
- IPG 8.9B
- CORT 8.1B
- IPO Year
- IPG N/A
- CORT N/A
- Fundamental
- Price
- IPG $23.41
- CORT $71.38
- Analyst Decision
- IPG Buy
- CORT Strong Buy
- Analyst Count
- IPG 9
- CORT 4
- Target Price
- IPG $33.22
- CORT $142.00
- AVG Volume (30 Days)
- IPG 8.9M
- CORT 1.4M
- Earning Date
- IPG 07-23-2025
- CORT 07-28-2025
- Dividend Yield
- IPG 5.67%
- CORT N/A
- EPS Growth
- IPG N/A
- CORT 8.36
- EPS
- IPG 1.31
- CORT 1.14
- Revenue
- IPG $9,001,000,000.00
- CORT $685,446,000.00
- Revenue This Year
- IPG N/A
- CORT $35.85
- Revenue Next Year
- IPG $2.74
- CORT $35.22
- P/E Ratio
- IPG $17.71
- CORT $62.59
- Revenue Growth
- IPG N/A
- CORT 30.93
- 52 Week Low
- IPG $22.51
- CORT $28.10
- 52 Week High
- IPG $33.05
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- IPG 45.65
- CORT 48.38
- Support Level
- IPG $22.74
- CORT $69.60
- Resistance Level
- IPG $23.52
- CORT $73.13
- Average True Range (ATR)
- IPG 0.54
- CORT 3.50
- MACD
- IPG 0.04
- CORT -0.18
- Stochastic Oscillator
- IPG 53.75
- CORT 24.77
About IPG Interpublic Group of Companies Inc. (The)
Interpublic Group is among the world's largest advertising holding companies based on annual revenue. It provides traditional advertising services along with digital and other services such as public relations through various acquisitions. IPG has made these services available in over 100 countries. The company generates about 65% of revenue in the US and 17% in the UK and Europe. IPG agreed to merge with Omnicom in December 2024, pending regulatory approval.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.